eye treatment biosimilar
Scope
Date
~
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharma applies for phase 3 trial in Taiwan for gout treatment
JW Pharmaceutical announced through its disclosure on Monday that it had applied last Friday for a phase 3 trial for Epaminurad, a gout treatment, w...
Dec 19, 2022 (Gmt+09:00)
-
Companies
S.Korea's e-commerce platform Plugo secures $9 million in investment
South Korea's Plugo, a comprehensive e-commerce platform based in Singapore, has attracted $9 million in Series A investment, the Silicon Valley, Ca...
Dec 16, 2022 (Gmt+09:00)
-
Corporate strategy
Samsung eyes new mobile AP chip to take on Apple's iPhone
Samsung Electronics Co. and Apple Inc. have had a long rivalry in the global market for smartphones and other mobile devices. In terms of sales...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's GI Cell, Japanese partner to study cell therapy for blood cancer
South Korea's GI Cell, the cell therapy affiliate of GI Innovation, on Tuesday said it signed an agreement with Optieum Biotechnologies of Japan on ...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Energy
Korean refiners eye strong 2022 earnings as margins improve
Asia’s benchmark refining margin is staging a rebound, providing relief for South Korea’s oil companies, which now expect their full-yea...
Nov 23, 2022 (Gmt+09:00)
-
Hydrogen economy
Doosan Fuel Cell expands exports with China deal
South Korea's Doosan Fuel Cell on Monday said it has signed an export contract worth 346.9 billion won($255 million) to supply large-scale versions ...
Nov 21, 2022 (Gmt+09:00)
-
Electronics
Vertu, Motorola, Xiaomi eye Korean smartphone market as LG exits
South Korea’s smartphone market is notoriously hard for foreign mobile phone makers to crack. So hard that some people call it the “grav...
Nov 18, 2022 (Gmt+09:00)
-
Banking & Finance
Daol Investment seeks to sell Thai subsidiary, eyes $75 mn in proceeds
South Korea’s Daol Investment & Securities Co. plans to sell a controlling stake in its Thai subsidiary, Daol Thailand PCL, as part of its...
Nov 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Waste management
BKT thrives as lone Korean wastewater treatment provider in US
South Korean water treatment provider Bukang Tech(BKT) on Wednesday said it earned a contract to build a wastewater treatment facility in the US sta...
Nov 18, 2022 (Gmt+09:00)
-
Shipping & Shipbuilding
Korea, US to work on Busan-Seattle green cargo shipping corridor
South Korea and the US are looking to create a green cargo shipping corridor linking the port of Busan with the ports of Seattle and Tacoma as part ...
Nov 16, 2022 (Gmt+09:00)
-
Food & Beverage
South Korean burger franchise Lotteria looks to the US for expansion
South Korea’s fast food franchise Lotteria is planning to enter the United States, home to the world’s best-known burger franchises.&nbs...
Nov 15, 2022 (Gmt+09:00)
-
Food & Beverage
Pulmuone to double pasta production in China by expanding plant
South Korea's food giant Pulmuone on Monday said it will boost production of pasta-based convenience food in China by expanding its first plant in P...
Nov 14, 2022 (Gmt+09:00)
-
Korean games
Game design and development studio SHIFT UP eyes IPO
SHIFT UP Corp., known for its subculture games, is eyeing an initial public offering (IPO.) The game design and development studio confirmed th...
Nov 14, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma's epilepsy treatment posts impressive growth in US
South Korean SK Biopharmaceuticals' epilepsy treatment Cenobamate has seen rapid growth on the US market.The company on Thursday said the medic...
Nov 11, 2022 (Gmt+09:00)
-
Companies
US water treatment juggernaut Culligan eyes Chungho Nais stake
Culligan, the biggest water treatment company in the United States, is set to become a major shareholder in South Korean water purifier rental firm ...
Nov 09, 2022 (Gmt+09:00)
-
Earnings
Kakao's Q3 profit drops 12% on games, data center construction
South Korea’s mobile platform giant Kakao Corp. announced its third-quarter earnings on Nov. 3, including quarterly operating profit of 150.3 ...
Nov 04, 2022 (Gmt+09:00)
-
Korean chipmakers
Samsung sets sights on new chips for self-driving homes on wheels
For decades, Samsung Electronics Co. has been a household name in the semiconductor industry, making chips that work like the human brain for comput...
Nov 03, 2022 (Gmt+09:00)
-
ASK 2022
KBIZ eyes value-added, senior loans for real estate
The Korea Federation of SMEs (KBIZ) bet on value-added and senior loans in global real estate investment this year, the institutional investors&rsqu...
Oct 28, 2022 (Gmt+09:00)
-
ASK 2022
Korea Post's insurance arm uses buyout, senior debt as core strategies
Korea Post’s insurance bureau will maintain its core-satellite strategy in private equity and debt investments for both stable revenue streams...
Oct 27, 2022 (Gmt+09:00)
-
ASK 2022
NPS considers new investment in global real estate
South Korea’s National Pension Service (NPS) is open to new investments in overseas real estate, the pension fund’s American real estate...
Oct 26, 2022 (Gmt+09:00)
-
ASK 2022
KFCC eyes recession-resistant sectors like healthcare, necessities
The Korean Federation of Community Credit Cooperatives (KFCC) is eyeing certain sectors that create stable revenue streams such as healthcare, daily...
Oct 26, 2022 (Gmt+09:00)